---
layout: post
title: "Mpox: Development of Drugs and Biological Products; Draft Guidance for Industry; Availability"
date: 2026-02-05 18:35:20 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-01029
original_published: 2023-01-20 00:00:00 +0000
significance: 8.00
---

# Mpox: Development of Drugs and Biological Products; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** January 20, 2023 00:00 UTC
**Document Number:** 2023-01029

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Mpox: Development of Drugs and Biological Products." FDA is issuing this guidance to support sponsors in their development of drugs and biological products for mpox.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/01/20/2023-01029/mpox-development-of-drugs-and-biological-products-draft-guidance-for-industry-availability)
- API: https://www.federalregister.gov/api/v1/documents/2023-01029

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
